Literature DB >> 34079743

A case study of glycogen storage disease type Ia presenting with multiple hepatocellular adenomas: an analysis by gadolinium ethoxybenzyl-diethylenetriamine-pentaacetic acid magnetic resonance imaging.

Xiaoming Li1, Hui Jing2, Lin Cheng1, Jie Xia3, Jian Wang1, Qing Li4, Chen Liu1, Ping Cai1.   

Abstract

Glycogen storage disease type Ia (GSD Ia) is a rare disease caused by a deficiency of hepatic glucose-6-phosphatase (G6Pase). Here, we report a 17-year-old Chinese boy with GSD Ia. Clinical manifestations of the patient included hepatomegaly, growth retardation, doll face, and biochemical abnormalities, including hypoglycaemia, hyperuricaemia, and hyperlipidaemia. The computed tomography (CT) and gadolinium ethoxybenzyl-diethylenetriamine-pentaacetic acid (Gd-EOB-DTPA) magnetic resonance imaging (MRI) revealed multiple masses in the left and right hemiliver. These masses presented as different dynamic enhanced patterns in the Gd-EOB-DTPA MRI. In addition, a large amount of glycogen deposit was detected in the liver tissue biopsy. Liver puncture confirmed that the masses were hepatocellular adenomas (HCAs). Genetic analyses confirmed the presence of liver metabolic disease, and the final clinical diagnostic was GSD Ia. The patient's clinical manifestations were significantly improved following regular treatment with raw corn starch for 9 months. Unfortunately, it was suspected that parts of the adenoma had undergone malignant transformation. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Glycogen storage disease (GSD); adenoma; gadolinium ethoxybenzyl-diethylenetriamine-pentaacetic acid (Gd-EOB-DTPA); gene; magnetic resonance imaging (MRI)

Year:  2021        PMID: 34079743      PMCID: PMC8107322          DOI: 10.21037/qims-20-746

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  20 in total

1.  The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a.

Authors:  M Veiga-da-Cunha; I Gerin; Y T Chen; P J Lee; J V Leonard; I Maire; U Wendel; M Vikkula; E Van Schaftingen
Journal:  Eur J Hum Genet       Date:  1999-09       Impact factor: 4.246

2.  Iso- or hyperintensity of hepatocellular adenomas on hepatobiliary phase does not always correspond to hepatospecific contrast-agent uptake: importance for tumor subtyping.

Authors:  Edouard Reizine; Maxime Ronot; Frederic Pigneur; Yvonne Purcell; Sebastien Mulé; Marco Dioguardi Burgio; Julien Calderaro; Giuliana Amaddeo; Alexis Laurent; Valérie Vilgrain; Alain Luciani
Journal:  Eur Radiol       Date:  2019-04-01       Impact factor: 5.315

Review 3.  Systematic review of haemorrhage and rupture of hepatocellular adenomas.

Authors:  S M van Aalten; R A de Man; J N M IJzermans; T Terkivatan
Journal:  Br J Surg       Date:  2012-05-22       Impact factor: 6.939

4.  Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification.

Authors:  Susanna M van Aalten; Maarten G J Thomeer; Türkan Terkivatan; Roy S Dwarkasing; Joanne Verheij; Robert A de Man; Jan N M Ijzermans
Journal:  Radiology       Date:  2011-08-26       Impact factor: 11.105

5.  Morphologic and Molecular Features of Hepatocellular Adenoma with Gadoxetic Acid-enhanced MR Imaging.

Authors:  Ahmed Ba-Ssalamah; Célia Antunes; Diana Feier; Nina Bastati; Jacqueline C Hodge; Judith Stift; Maria A Cipriano; Friedrich Wrba; Michael Trauner; Christian J Herold; Filipe Caseiro-Alves
Journal:  Radiology       Date:  2015-05-18       Impact factor: 11.105

6.  Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.

Authors:  Jean-Charles Nault; Gabrielle Couchy; Charles Balabaud; Guillaume Morcrette; Stefano Caruso; Jean-Frederic Blanc; Yannick Bacq; Julien Calderaro; Valérie Paradis; Jeanne Ramos; Jean-Yves Scoazec; Viviane Gnemmi; Nathalie Sturm; Catherine Guettier; Monique Fabre; Eric Savier; Laurence Chiche; Philippe Labrune; Janick Selves; Dominique Wendum; Camilla Pilati; Alexis Laurent; Anne De Muret; Brigitte Le Bail; Sandra Rebouissou; Sandrine Imbeaud; Paulette Bioulac-Sage; Eric Letouzé; Jessica Zucman-Rossi
Journal:  Gastroenterology       Date:  2016-12-07       Impact factor: 22.682

Review 7.  Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.

Authors:  Janice Y Chou; Hyun Sik Jun; Brian C Mansfield
Journal:  J Inherit Metab Dis       Date:  2014-10-07       Impact factor: 4.982

8.  A nomogram based on bi-regional radiomics features from multimodal magnetic resonance imaging for preoperative prediction of microvascular invasion in hepatocellular carcinoma.

Authors:  Rui Zhang; Lei Xu; Xue Wen; Jiahui Zhang; Pengfei Yang; Lixia Zhang; Xing Xue; Xiaoli Wang; Qiang Huang; Chuangen Guo; Yanjun Shi; Tianye Niu; Feng Chen
Journal:  Quant Imaging Med Surg       Date:  2019-09

9.  Glycogen storage disease type Ia: Adult presentation with microcytic anemia and liver adenomas.

Authors:  Wouter Moest; Wendy van der Deure; Ted Koster; Marcela Spee-Dropková; Linda Swart-Busscher; Robbert J de Haas; Terry G J Derks
Journal:  Hepatology       Date:  2018-04-27       Impact factor: 17.425

10.  Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?

Authors:  Timo Alexander Auer; Uli Fehrenbach; Christian Grieser; Tobias Penzkofer; Dominik Geisel; Moritz Schmelzle; Tobias Müller; Hendrik Bläker; Daniel Seehofer; Timm Denecke
Journal:  Eur Radiol       Date:  2020-02-21       Impact factor: 5.315

View more
  1 in total

Review 1.  Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?

Authors:  Xiaoming Li; Qiandong Yao; Chen Liu; Jian Wang; Huarong Zhang; Shiguang Li; Ping Cai
Journal:  J Hepatocell Carcinoma       Date:  2022-05-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.